{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:04:52Z","timestamp":1768442692422,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microvascular dysfunction has been suggested to trigger adipose tissue dysfunction in obesity. This study investigates the hypothesis that glycation impairs microvascular architecture and expandability with an impact on insulin signalling. Animal models supplemented with methylglyoxal (MG), maintained with a high-fat diet (HFD) or both (HFDMG) were studied for periepididymal adipose (pEAT) tissue hypoxia and local and systemic insulin resistance. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) was used to quantify blood flow <jats:italic>in vivo<\/jats:italic>, showing MG-induced reduction of pEAT blood flow. Increased adipocyte size and leptin secretion were observed only in rats feeding the high-fat diet, without the development of hypoxia. In turn, hypoxia was only observed when MG was combined (HFDMG group), being associated with impaired activation of the insulin receptor (Tyr1163), glucose intolerance and systemic and muscle insulin resistance. Accordingly, the adipose tissue angiogenic assay has shown decreased capillarization after dose-dependent MG exposure and glyoxalase-1 inhibition. Thus, glycation impairs adipose tissue capillarization and blood flow, hampering its expandability during a high-fat diet challenge and leading to hypoxia and insulin resistance. Such events have systemic repercussions in glucose metabolism and may lead to the onset of unhealthy obesity and progression to type 2 diabetes.<\/jats:p>","DOI":"10.1038\/s41598-017-01730-3","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T14:11:04Z","timestamp":1493907064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance"],"prefix":"10.1038","volume":"7","author":[{"given":"Tiago","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"Paulo","family":"Matafome","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Sereno","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-1515","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Castelhano","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Gamas","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Neves","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Amina","family":"Arslanagic","sequence":"additional","affiliation":[]},{"given":"Elinor","family":"Wilcken","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Ilda","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Silvia Vilares","family":"Conde","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-6373","authenticated-orcid":false,"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Sei\u00e7a","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-014-0441-1","volume":"16","author":"P Boonchaya-anant","year":"2014","unstructured":"Boonchaya-anant, P. & Apovian, C. M. Metabolically Healthy Obesity\u2014Does it Exist? Curr. Atheroscler. Rep. \n                           16, 1\u20139, doi:10.1007\/s11883-014-0441-1 (2014).","journal-title":"Curr. Atheroscler. Rep."},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/eurheartj\/ehu123","volume":"36","author":"G-M Hinnouho","year":"2014","unstructured":"Hinnouho, G.-M. et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Hear. J. \n                           36, 551\u2013559, doi:10.1093\/eurheartj\/ehu123 (2014).","journal-title":"Eur. Hear. J."},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3945\/an.115.008433","volume":"6","author":"J Uribarri","year":"2015","unstructured":"Uribarri, J. et al. Dietary Advanced Glycation End Products and Their Role in Health and Disease. Adv. Nutr. An Int. Rev. J. \n                           6, 461\u2013473, doi:10.3945\/an.115.008433 (2015).","journal-title":"Adv. Nutr. An Int. Rev. J."},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrm2391","volume":"114","author":"A Guilherme","year":"2008","unstructured":"Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. \n                           114, 715\u201328, doi:10.1038\/nrm2391 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbadis.2013.06.003","volume":"1842","author":"S Corvera","year":"2014","unstructured":"Corvera, S. & Gealekman, O. Adipose tissue angiogenesis: Impact on obesity and type-2 diabetes. Biochim. Biophys. Acta. \n                           1842, 463\u2013472, doi:10.1016\/j.bbadis.2013.06.003 (2014).","journal-title":"Biochim. Biophys. Acta."},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg, H. & Moschen, A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. \n                           6, 772\u201383, doi:10.1038\/nri1937 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13813455.2013.838971","volume":"120","author":"T Rodrigues","year":"2013","unstructured":"Rodrigues, T., Matafome, P. & Sei\u00e7a, R. A vascular piece in the puzzle of adipose tissue dysfunction: mechanisms and consequences. Arch. Physiol. Biochem. \n                           120, 1\u201311, doi:10.3109\/13813455.2013.838971 (2013).","journal-title":"Arch. Physiol. Biochem."},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.2337\/db10-0483","volume":"59","author":"S Hocking","year":"2010","unstructured":"Hocking, S., Wu, L. & Guilhaus, M. Intrinsic Depot-Specific Differences in the Secretome of Adipose Tissue, Preadipocytes, and Adipose Tissue\u2013Derived Microvascular Endothelial Cells. Diabetes. \n                           59, 3008\u20133016, doi:10.2337\/db10-0483 (2010).","journal-title":"Diabetes."},{"key":"1730_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867322666150209155633","volume":"22","author":"P Matafome","year":"2015","unstructured":"Matafome, P., Rodrigues, T. & Sei\u00e7a, R. Glycation and hypoxia: two key factors for adipose tissue dysfunction. Curr. Med. Chem. \n                           22, 1\u201321, doi:10.2174\/0929867322666150209155633 (2015).","journal-title":"Curr. Med. Chem."},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"K Wellen","year":"2003","unstructured":"Wellen, K. & Hotamisligil, G. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. \n                           112, 1785\u20131788, doi:10.1172\/JCI20514 (2003).","journal-title":"J. Clin. Invest."},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"E1118","DOI":"10.1152\/ajpendo.00435.2007","volume":"293","author":"J Ye","year":"2007","unstructured":"Ye, J., Gao, Z., Yin, J. & He, Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob\/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. \n                           293, E1118\u201328, doi:10.1152\/ajpendo.00435.2007 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0007114508971282","volume":"100","author":"P Trayhurn","year":"2008","unstructured":"Trayhurn, P., Wang, B. & Wood, I. S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr. \n                           100, 227\u201335, doi:10.1017\/S0007114508971282 (2008).","journal-title":"Br. J. Nutr."},{"key":"1730_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2012","volume":"93","author":"P Trayhurn","year":"2013","unstructured":"Trayhurn, P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. \n                           93, 1\u201321, doi:10.1152\/physrev.00017.2012 (2013).","journal-title":"Physiol. Rev."},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.111.027813","volume":"124","author":"GH Goossens","year":"2011","unstructured":"Goossens, G. H. et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation. \n                           124, 67\u201376, doi:10.1161\/CIRCULATIONAHA.111.027813 (2011).","journal-title":"Circulation."},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1007\/s00125-012-2658-2","volume":"55","author":"O Gealekman","year":"2012","unstructured":"Gealekman, O. et al. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial. Diabetologia. \n                           55, 2794\u20132799, doi:10.1007\/s00125-012-2658-2 (2012).","journal-title":"Diabetologia."},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s00125-012-2651-9","volume":"55","author":"L Manner\u00e5s-Holm","year":"2012","unstructured":"Manner\u00e5s-Holm, L. & Krook, A. Targeting adipose tissue angiogenesis to enhance insulin sensitivity. Diabetologia. \n                           55, 2562\u20134, doi:10.1007\/s00125-012-2651-9 (2012).","journal-title":"Diabetologia."},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1111\/j.1742-4658.2009.07303.x","volume":"276","author":"JM Rutkowski","year":"2009","unstructured":"Rutkowski, J. M., Davis, K. E. & Scherer, P. E. Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J. \n                           276, 5738\u201346, doi:10.1111\/j.1742-4658.2009.07303.x (2009).","journal-title":"FEBS J."},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cmet.2013.08.008","volume":"18","author":"Y Cao","year":"2013","unstructured":"Cao, Y. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. Cell Metab. \n                           18, 478\u201389, doi:10.1016\/j.cmet.2013.08.008 (2013).","journal-title":"Cell Metab."},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature. \n                           414, 813\u201320, doi:10.1038\/414813a (2001).","journal-title":"Nature."},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. \n                           54, 1615\u201325, doi:10.2337\/diabetes.54.6.1615 (2005).","journal-title":"Diabetes."},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin, A., Beckman, J., Schmidt, A. M. & Creager, M. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation \n                           114, 597\u2013605 (2006).","journal-title":"Circulation"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1089\/ars.2009.2484","volume":"11","author":"A Negre-Salvayre","year":"2009","unstructured":"Negre-Salvayre, A. et al. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox Signal. \n                           11, 3071\u2013109, doi:10.1089\/ars.2009.2484 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12020-012-9795-8","volume":"43","author":"P Matafome","year":"2013","unstructured":"Matafome, P., Sena, C. & Sei\u00e7a, R. Methylglyoxal, obesity, and diabetes. Endocrine. \n                           43, 472\u201384, doi:10.1007\/s12020-012-9795-8 (2013).","journal-title":"Endocrine."},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2337\/db10-0627","volume":"60","author":"A Dhar","year":"2011","unstructured":"Dhar, A., Dhar, I., Jiang, B., Desai, K. M. & Wu, L. Chronic methylglyoxal infusion by minipump causes pancreatic beta-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes. \n                           60, 899\u2013908, doi:10.2337\/db10-0627 (2011).","journal-title":"Diabetes."},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diabres.2006.09.016","volume":"76","author":"H Unoki","year":"2007","unstructured":"Unoki, H. et al. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res. Clin. Pract. \n                           76, 236\u201344, doi:10.1016\/j.diabres.2006.09.016 (2007).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-007-9563-x","volume":"306","author":"X Jia","year":"2007","unstructured":"Jia, X. & Wu, L. Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol. Cell. Biochem. \n                           306, 133\u2013139, doi:10.1007\/s11010-007-9563-x (2007).","journal-title":"Mol. Cell. Biochem."},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0006-2952(97)00619-9","volume":"55","author":"LJ Cook","year":"1998","unstructured":"Cook, L. J. et al. Effects of methylglyoxal on rat pancreatic beta-cells. Biochem. Pharmacol. \n                           55, 1361\u20137, doi:10.1016\/S0006-2952(97)00619-9 (1998).","journal-title":"Biochem. Pharmacol."},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00125-011-2280-8","volume":"54","author":"F Fiory","year":"2011","unstructured":"Fiory, F. et al. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia. \n                           54, 2941\u201352, doi:10.1007\/s00125-011-2280-8 (2011).","journal-title":"Diabetologia."},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","volume":"51","author":"SMS Hofmann","year":"2002","unstructured":"Hofmann, S. M. S. et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db\/db mouse. Diabetes. \n                           51, 2082\u20132089, doi:10.2337\/diabetes.51.7.2082 (2002).","journal-title":"Diabetes."},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/13813455.2012.658065","volume":"118","author":"P Matafome","year":"2012","unstructured":"Matafome, P. et al. Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity. Arch. Physiol. Biochem. \n                           118, 58\u201368, doi:10.3109\/13813455.2012.658065 (2012).","journal-title":"Arch. Physiol. Biochem."},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"690650","DOI":"10.1155\/2013\/690650","volume":"2013","author":"T Rodrigues","year":"2013","unstructured":"Rodrigues, T., Paulo, M., Santos-Silva, D., Sena, C. & Sei\u00e7a, R. Reduction of methylglyoxal-induced glycation by pyridoxamine improves adipose tissue microvascular lesions. J. Diabetes Res. \n                           2013, 690650,\u00a0doi:10.1155\/2013\/690650 (2013).","journal-title":"J. Diabetes Res."},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/13813455.2013.812121","volume":"119","author":"T Rodrigues","year":"2013","unstructured":"Rodrigues, T., Matafome, P. & Sei\u00e7a, R. Methylglyoxal further impairs adipose tissue metabolism after partial decrease of blood supply. Arch. Physiol. Biochem. \n                           119, 209\u2013218, doi:10.3109\/13813455.2013.812121 (2013).","journal-title":"Arch. Physiol. Biochem."},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1113\/expphysiol.2010.053561","volume":"95","author":"CF Bento","year":"2010","unstructured":"Bento, C. F. et al. Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction. Exp. Physiol. \n                           95, 955\u201370, doi:10.1113\/expphysiol.2010.053561 (2010).","journal-title":"Exp. Physiol."},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"970375","DOI":"10.1155\/2015\/970375","volume":"2015","author":"I Moreno-Indias","year":"2015","unstructured":"Moreno-Indias, I. & Tinahones, F. J. Impaired Adipose Tissue Expandability and Lipogenic Capacities as Ones of the Main Causes of Metabolic Disorders. J. Diabetes Res. \n                           2015, 970375\u201312, doi:10.1155\/2015\/970375 (2015).","journal-title":"J. Diabetes Res."},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1210\/jc.2014-3925","volume":"100","author":"J Uribarri","year":"2015","unstructured":"Uribarri, J. et al. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? J. Clin. Endocrinol. Metab. \n                           100, 1957\u201366, doi:10.1210\/jc.2014-3925 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0024-3205(98)00336-1","volume":"63","author":"J Golej","year":"1998","unstructured":"Golej, J., Hoeger, H., Radner, W., Unfried, G. & Lubec, G. Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci. \n                           63, 801\u20137, doi:10.1016\/S0024-3205(98)00336-1 (1998).","journal-title":"Life Sci."},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/CS20050026","volume":"109","author":"J Berlanga","year":"2005","unstructured":"Berlanga, J. et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin. Sci. \n                           109, 83\u201395, doi:10.1042\/CS20050026 (2005).","journal-title":"Clin. Sci."},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2337\/db06-0911","volume":"56","author":"N Hosogai","year":"2007","unstructured":"Hosogai, N. et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. \n                           56, 901\u201311, doi:10.2337\/db06-0911 (2007).","journal-title":"Diabetes."},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/MCB.00192-09","volume":"29","author":"N Halberg","year":"2009","unstructured":"Halberg, N. et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. \n                           29, 4467\u201383, doi:10.1128\/MCB.00192-09 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"1730_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2015.00055","volume":"6","author":"GH Goossens","year":"2015","unstructured":"Goossens, G. H. & Blaak, E. E. Adipose Tissue Dysfunction and Impaired Metabolic Health in Human Obesity: A Matter of Oxygen? Front. Endocrinol. \n                           6, 1\u20135, doi:10.3389\/fendo.2015.00055 (2015).","journal-title":"Front. Endocrinol."},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1161\/ATVBAHA.111.235846","volume":"32","author":"MGM Farb","year":"2012","unstructured":"Farb, M. G. M. et al. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler. Thromb. Vasc. Biol. \n                           32, 467\u201373, doi:10.1161\/ATVBAHA.111.235846 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1730_CR42","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.2337\/diabetes.51.8.2467","volume":"51","author":"F Karpe","year":"2002","unstructured":"Karpe, F. et al. Impaired Postprandial Adipose Tissue Blood Flow Response Is Related to Aspects of Insulin Sensitivity. Diabetes. \n                           51, 2467\u20132473, doi:10.2337\/diabetes.51.8.2467 (2002).","journal-title":"Diabetes."},{"key":"1730_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0015062","volume":"5","author":"CF Bento","year":"2010","unstructured":"Bento, C. F. et al. The chaperone-dependent ubiquitin ligase CHIP targets HIF-1\u03b1 for degradation in the presence of methylglyoxal. PLoS One \n                           5, 1\u201313, doi:10.1371\/journal.pone.0015062 (2010).","journal-title":"PLoS One"},{"key":"1730_CR44","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2337\/db13-1965","volume":"63","author":"SS Choe","year":"2014","unstructured":"Choe, S. S. et al. Macrophage HIF-2\u03b1 ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes. \n                           63, 3359\u20133371, doi:10.2337\/db13-1965 (2014).","journal-title":"Diabetes."},{"key":"1730_CR45","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2337\/db14-0878","volume":"63","author":"M Aouadi","year":"2014","unstructured":"Aouadi, M. HIF-2 Blows Out the Flames of Adipose Tissue Macrophages to Keep Obesity in a Safe Zone. Diabetes. \n                           63, 3169\u20133171, doi:10.2337\/db14-0878 (2014).","journal-title":"Diabetes."},{"key":"1730_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2337\/db14-0352","volume":"64","author":"K J\u00f6rgens","year":"2015","unstructured":"J\u00f6rgens, K. et al. High Tissue Glucose Alters Intersomitic Blood Vessels in Zebrafish via Methylglyoxal Targeting the VEGF Receptor Signaling Cascade. Diabetes. \n                           64, 213\u2013225, doi:10.2337\/db14-0352 (2015).","journal-title":"Diabetes."},{"key":"1730_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.174","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2 \u2212 \u03b1 v \u03b2 3 integrin cross-talk. Cell death Dis. \n                           6, 1\u20138, doi:10.1038\/cddis.2015.174 (2015).","journal-title":"Cell death Dis."},{"key":"1730_CR48","doi-asserted-by":"publisher","first-page":"E1056","DOI":"10.1152\/ajpendo.90345.2008","volume":"295","author":"O Gealekman","year":"2008","unstructured":"Gealekman, O. et al. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am. J. Physiol. Endocrinol. Metab. \n                           295, E1056\u201364, doi:10.1152\/ajpendo.90345.2008 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1730_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-411619-1.00005-7","volume":"537","author":"R Rojas-Rodriguez","year":"2014","unstructured":"Rojas-Rodriguez, R. et al. Adipose Tissue Angiogenesis Assay Raziel. Methods Enzym. \n                           537, 75\u201391, doi:10.1016\/B978-0-12-411619-1.00005-7 (2014).","journal-title":"Methods Enzym."},{"key":"1730_CR50","doi-asserted-by":"publisher","first-page":"e46720","DOI":"10.1371\/journal.pone.0046720","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu, H., Yu, S., Zhang, H. & Xu, J. Angiogenesis Impairment in Diabetes: Role of Methylglyoxal-Induced Receptor for Advanced Glycation Endproducts, Autophagy and Vascular Endothelial Growth Factor Receptor 2. PLoS One \n                           7, e46720, doi:10.1371\/journal.pone.0046720 (2012).","journal-title":"PLoS One"},{"key":"1730_CR51","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1172\/JCI81507","volume":"125","author":"U Smith","year":"2015","unstructured":"Smith, U. Abdominal obesity: a marker of ectopic fat accumulation. J clin invest. \n                           125, 1790\u20131792, doi:10.1172\/JCI81507 (2015).","journal-title":"J clin invest."},{"key":"1730_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.physbeh.2007.10.010","volume":"94","author":"GH Goossens","year":"2008","unstructured":"Goossens, G. H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. \n                           94, 206\u201318, doi:10.1016\/j.physbeh.2007.10.010 (2008).","journal-title":"Physiol. Behav."},{"key":"1730_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MOL.0b013e32835aea13","volume":"24","author":"KHJ Gaens","year":"2013","unstructured":"Gaens, K. H. J., Stehouwer, C. D. A. & Schalkwijk, C. G. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr. Opin. Lipidol. \n                           24, 4\u201311 (2013).","journal-title":"Curr. Opin. Lipidol."},{"key":"1730_CR54","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","volume":"34","author":"KHJ Gaens","year":"2014","unstructured":"Gaens, K. H. J. et al. N\u03b5-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler. Thromb. Vasc. Biol. \n                           34, 1199\u20131208, doi:10.1161\/ATVBAHA.113.302281 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1730_CR55","doi-asserted-by":"publisher","first-page":"e1004436","DOI":"10.1371\/journal.pcbi.1004436","volume":"11","author":"P Santos-Oliveira","year":"2015","unstructured":"Santos-Oliveira, P. et al. The Force at the Tip\u2013Modelling Tension and Proliferation in Sprouting Angiogenesis. PLoS Comput. Biol. \n                           11, e1004436, doi:10.1371\/journal.pcbi.1004436 (2015).","journal-title":"PLoS Comput. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01730-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01730-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01730-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:13:11Z","timestamp":1671768791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01730-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01730-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]},"assertion":[{"value":"12 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1698"}}